BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Nonalcoholic steatohepatitis
1
Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease
1/27/2026 10:12:30 AM | Browse: 36 | Download: 81
2
Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends
12/5/2025 11:28:02 AM | Browse: 72 | Download: 176
3
Pathological features of non-alcoholic steatohepatitis in a pediatric patient with heterozygous familial hypobetalipoproteinemia: A case report
2/20/2025 8:39:54 AM | Browse: 160 | Download: 613
4
Revolutionizing the understanding of liver disease: Metabolism, function and future
11/29/2024 2:50:19 PM | Browse: 175 | Download: 771
5
Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis
10/25/2024 3:02:15 AM | Browse: 181 | Download: 695
6
Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1
12/27/2023 5:42:53 AM | Browse: 321 | Download: 1208
7
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
5/24/2023 9:31:05 AM | Browse: 417 | Download: 1296
8
New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders
3/28/2023 12:59:29 PM | Browse: 369 | Download: 919
9
Emerging role of engineered exosomes in nonalcoholic fatty liver disease
3/22/2023 11:20:34 AM | Browse: 449 | Download: 1449
10
Microbiome-liver crosstalk: A multihit therapeutic target for liver disease
3/17/2023 6:20:53 AM | Browse: 452 | Download: 1254
11
Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
1/6/2023 2:52:58 AM | Browse: 473 | Download: 982
12
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma
1/6/2023 2:52:58 AM | Browse: 465 | Download: 1216
13
Management of metabolic-associated fatty liver disease: The diabetology perspective
1/4/2023 5:53:02 AM | Browse: 463 | Download: 1063
14
Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies
1/4/2023 5:53:01 AM | Browse: 464 | Download: 1408
15
Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease
10/28/2022 7:46:25 AM | Browse: 616 | Download: 1945
16
Heredity hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study
9/23/2022 12:48:56 AM | Browse: 642 | Download: 1999
17
Nonalcoholic fatty liver disease and diabetes
9/9/2022 3:45:24 PM | Browse: 748 | Download: 1737
18
Simple diagnostic algorithm identifying at-risk nonalcoholic fatty liver disease patients needing specialty referral within the United States
8/26/2022 9:51:35 AM | Browse: 633 | Download: 1745
19
Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis
5/24/2022 10:35:19 AM | Browse: 704 | Download: 1653
20
Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
2/22/2022 9:25:37 AM | Browse: 747 | Download: 1811
21
Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study
12/27/2021 5:24:01 AM | Browse: 765 | Download: 2100
22
Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
11/24/2021 9:54:22 AM | Browse: 726 | Download: 1850
23
Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
8/20/2021 9:33:19 AM | Browse: 945 | Download: 2093
24
PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
7/6/2021 2:31:17 AM | Browse: 754 | Download: 2144
25
Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
4/29/2021 2:12:02 AM | Browse: 856 | Download: 2000
26
Adult human liver slice cultures: Modelling of liver fibrosis and evaluation of new anti-fibrotic drugs
2/25/2021 3:45:30 PM | Browse: 784 | Download: 2040
27
Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system
1/25/2021 6:05:27 AM | Browse: 743 | Download: 2046
28
Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis
12/14/2020 8:10:05 AM | Browse: 977 | Download: 2516
29
Advances in the treatment of nonalcoholic steatohepatitis
10/29/2020 5:34:30 AM | Browse: 1157 | Download: 2227
30
PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
10/24/2020 2:27:20 AM | Browse: 1047 | Download: 2226
31
Role of betaine in liver disease-worth revisiting or has the die been cast?
10/14/2020 11:33:23 AM | Browse: 911 | Download: 2019
32
Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?
9/21/2020 4:02:08 PM | Browse: 783 | Download: 2618
33
Management of nonalcoholic fatty liver disease in the Middle East
7/7/2020 2:50:53 PM | Browse: 1051 | Download: 1834
34
Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
6/19/2020 9:46:52 AM | Browse: 1198 | Download: 2443
35
Natural products that target macrophages in treating non-alcoholic steatohepatitis
5/14/2020 3:43:04 AM | Browse: 1171 | Download: 2147
36
L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis
2/28/2020 10:08:51 AM | Browse: 1367 | Download: 2414
37
Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
9/7/2019 4:43:36 AM | Browse: 1203 | Download: 2567
38
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
6/28/2019 12:22:27 PM | Browse: 1340 | Download: 2572
39
Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats
5/28/2019 9:29:42 AM | Browse: 1257 | Download: 2850
40
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 1427 | Download: 2325
41
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 1204 | Download: 1873
42
Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions
12/6/2018 1:35:45 PM | Browse: 1456 | Download: 2726
43
Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?
11/27/2018 1:56:41 PM | Browse: 1136 | Download: 1911
44
Current status of imaging in nonalcoholic fatty liver disease
8/27/2018 12:43:23 PM | Browse: 1508 | Download: 1899
45
Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
8/27/2018 7:22:43 AM | Browse: 1328 | Download: 1754
46
Apoptosis and non-alcoholic fatty liver diseases
7/5/2018 1:33:43 AM | Browse: 1379 | Download: 2153
47
Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis
6/15/2018 9:13:16 AM | Browse: 1469 | Download: 2890
48
Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
5/11/2018 10:51:26 AM | Browse: 1095 | Download: 1760
49
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
4/27/2018 3:25:40 AM | Browse: 1550 | Download: 1911
50
Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis
4/19/2018 7:56:07 AM | Browse: 1690 | Download: 2603